Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2017-04-13

Clinical Trial Update: Study To Test Whether PF-00547659 Is Safe And Improves Disease Symptoms In Patients With Crohn's Disease [Phase 2]

View source ↗

Summary

Phase 2 clinical trial evaluating PF-00547659 for safety and symptom improvement in Crohn's disease has completed with results posted.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • PF-00547659

Snippet

Sponsor: Shire | Conditions: Crohn's Disease | Phase 2 | Status: COMPLETED | Results posted: 2017-04-13